Dexcom G6 Continuous Glucose Monitoring System

Integrated Continuous Glucose Monitoring System, Factory Calibrated

Dexcom, Inc.

The following data is part of a De Novo classification by Dexcom, Inc. with the FDA for Dexcom G6 Continuous Glucose Monitoring System.

Pre-market Notification Details

DeNovo IDDEN170088
Device Name:Dexcom G6 Continuous Glucose Monitoring System
ClassificationIntegrated Continuous Glucose Monitoring System, Factory Calibrated
Applicant Dexcom, Inc. 6340 Sequence Dr San Diego,  CA  92121
ContactNeeta Sharma
Product CodeQBJ  
CFR Regulation Number862.1355 [🔎]
DecisionGranted (DENG)
510(k) Premarket NotificationDevice Classification Under Section 513(f)(2)(de Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin
Review Advisory BoardClinical Chemistry
Classification AdvisoryClinical Chemistry
TypeDirect
Date Received2017-12-08
Decision Date2018-03-27
FDA ReviewDecision Summary
Reclassification Order:Reclassification Order

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00386270000811 DEN170088 000
00386270001061 DEN170088 000
00386270001900 DEN170088 000
00386270001627 DEN170088 000
00386270000590 DEN170088 000
00386270001931 DEN170088 000
00386270001917 DEN170088 000
80386270000251 DEN170088 000
70386270000254 DEN170088 000
00386270001092 DEN170088 000
00386270001641 DEN170088 000
00386270000804 DEN170088 000
00386270000583 DEN170088 000
00386270000385 DEN170088 000
00386270000255 DEN170088 000
10386270001037 DEN170088 000
00386270001788 DEN170088 000
00386270001771 DEN170088 000
00386270001764 DEN170088 000
60386270000257 DEN170088 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.